跳至主要内容
临床试验/NCT07252102
NCT07252102招募中不适用

Effect of High Flow Nasal Cannula Oxygenation on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients : A Multicentre Randomised Controlled Trial.

Zhejiang University2 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2025年6月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
450
试验地点
2
主要终点
Incidence of hypoxia

研究概览

简要总结

High flow nasal cannula oxygenation (HFNC) offers high flow and concentration oxygen delivery, providing excellent non-respiratory oxygenation. As a relatively new oxygen delivery method, it has gained widespread use. We have demonstrated that high flow nasal cannula oxygenation reduce the incidence of hypoxia during sedated gastrointestinal endoscopy in patients with American Anesthesiologist Rating (ASA rating) grades 1 to 2 and obesity. We hypothesized that HFNC could mitigate the risk of hypoxia in critical patients during sedated gastrointestinal endoscopy. To confirm this, we selected critical patients with ASA grades 3 to 4 who were scheduled for gastrointestinal endoscopy. We observed and compared the incidence of hypoxia (75%≤SpO2 < 90% and < 60S), severe hypoxia (SpO2<75% for any duration or 75%≤SpO2 < 90%, ≥60s), subclinical respiratory depression (90%≤SpO2 < 95%), respiratory-related adverse events, sedation-related adverse events, and complications associated with high flow nasal cannula oxygenation using HFNC or regular nasal cannula during the sedated gastrointestinal endoscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •18≤ age ≤80, gender is not limited;
  • •Patients undergoing elective gastroenteroscopy or treatment;
  • •ASA grade Ⅲ~Ⅳ;
  • •18 kg/m2≤BMI≤28kg/m2;
  • •The operation time of gastroenteroscopy is expected to be no more than 60min;
  • •Clearly understand, voluntarily participate in the study, and have informed consent from myself or my family members.

排除标准

  • •Patients with nasal congestion, nasal bleeding, recent nasal trauma, recent nasal surgery, increased intracranial pressure and skull fracture, etc., who can not perform high-flow nasal catheter oxygen;
  • •acute respiratory infections and asthma attacks;
  • •Patients diagnosed with COPD;
  • •Clear difficult airway;
  • •Acute upper gastrointestinal bleeding with shock;
  • •Gastrointestinal obstruction with gastric content retention;
  • •Allergic to sedatives such as propofol;
  • •Persons with no capacity for civil conduct such as cognitive dysfunction.

研究组 & 干预措施

High-flow nasal catheter oxygen

Experimental

干预措施: High-flow nasal catheter oxygen (Device)

Regular nasal catheter oxygen

Active Comparator

干预措施: regular nasal catheter oxygen (Device)

结局指标

主要结局

Incidence of hypoxia

时间窗: Patients will be followed for the duration of hospital stay, an expected average about 2 hours

75%≤ SpO2 \< 90% and \< 60S

次要结局

  • Incidence of severe hypoxia(Patients will be followed for the duration of hospital stay, an expected average about 2 hours)
  • Incidence of subclinical respiratory depression(Patients will be followed for the duration of hospital stay, an expected average about 2 hours)

研究者

发起方
Zhejiang University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Diansan Su

Chief, Department of Anesthesiology, the First Affiliated Hospital of Zhejiang University School of Medicine

Zhejiang University

研究点 (2)

Loading locations...

相似试验